Townsquare Capital LLC Takes $4.12 Million Position in Chemed Co. (NYSE:CHE)

Townsquare Capital LLC bought a new stake in Chemed Co. (NYSE:CHE - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 6,848 shares of the company's stock, valued at approximately $4,115,000.

Several other large investors also recently made changes to their positions in CHE. BNP Paribas Financial Markets grew its stake in Chemed by 36.2% in the third quarter. BNP Paribas Financial Markets now owns 26,381 shares of the company's stock valued at $15,854,000 after acquiring an additional 7,007 shares during the period. FMR LLC lifted its holdings in shares of Chemed by 23.8% in the 3rd quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after purchasing an additional 45,917 shares in the last quarter. Loomis Sayles & Co. L P grew its position in Chemed by 0.4% in the 3rd quarter. Loomis Sayles & Co. L P now owns 29,159 shares of the company's stock valued at $17,523,000 after purchasing an additional 108 shares during the period. Centaurus Financial Inc. increased its stake in Chemed by 136.2% during the 3rd quarter. Centaurus Financial Inc. now owns 5,071 shares of the company's stock valued at $3,048,000 after purchasing an additional 2,924 shares in the last quarter. Finally, Algert Global LLC raised its holdings in Chemed by 100.2% during the third quarter. Algert Global LLC now owns 23,100 shares of the company's stock worth $13,882,000 after buying an additional 11,560 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the sale, the chief executive officer now owns 103,735 shares of the company's stock, valued at approximately $62,117,555.35. This trade represents a 1.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the company's stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $569.35, for a total transaction of $975,296.55. Following the sale, the executive vice president now directly owns 6,109 shares in the company, valued at approximately $3,478,159.15. This trade represents a 21.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,845 shares of company stock valued at $3,978,798. Insiders own 3.32% of the company's stock.

Chemed Stock Up 0.2 %

NYSE:CHE traded up $1.08 during trading hours on Friday, hitting $572.39. 45,670 shares of the company traded hands, compared to its average volume of 85,970. Chemed Co. has a one year low of $523.33 and a one year high of $654.62. The company has a market cap of $8.61 billion, a PE ratio of 28.96, a PEG ratio of 2.42 and a beta of 0.46. The firm's 50-day simple moving average is $578.27 and its 200-day simple moving average is $565.09.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to analysts' expectations of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the firm posted $5.32 earnings per share. As a group, equities research analysts expect that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed's payout ratio is 10.11%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Royal Bank of Canada reduced their price objective on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Saturday.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.